Dishman Carbogen Amcis Ltd Share Price – NSE /  BSE

Pharmaceuticals, Small Cap

Dishman Carbogen Amcis announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 19 June 2026.

Net profit of Dishman Carbogen Amcis declined 49.55% to Rs 21.74 crore in the quarter ended March 2026 as against Rs 43.09 crore during the previous quarter ended March 2025. Sales rose 18.85% to Rs 851.40 crore in the quarter ended March 2026 as against Rs 716.34 crore during the previous quarter ended March 2025.

For the full year,net profit rose 2907.72% to Rs 97.45 crore in the year ended March 2026 as against Rs 3.24 crore during the previous year ended March 2025. Sales rose 8.13% to Rs 2931.90 crore in the year ended March 2026 as against Rs 2711.50 crore during the previous year ended March 2025.

Powered by Capital Market - Live News

Dishman Carbogen Amcis will hold a meeting of the Board of Directors of the Company on 19 May 2026.

Net loss of Dishman Carbogen Amcis reported to Rs 12.97 crore in the quarter ended December 2025 as against net profit of Rs 4.63 crore during the previous quarter ended December 2024. Sales rose 5.49% to Rs 719.80 crore in the quarter ended December 2025 as against Rs 682.34 crore during the previous quarter ended December 2024.

Powered by Capital Market - Live News